List of works - Guido Veit

Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity

scientific article published on 16 July 2019

Chaperone-Independent Peripheral Quality Control of CFTR by RFFL E3 Ligase.

scientific article published in March 2018

Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.

scientific article published on 30 August 2017

Collagen XII interacts with avian tenascin-X through its NC3 domain

scientific article published on 21 July 2006

Collagen XXII binds to collagen-binding integrins via the novel motifs GLQGER and GFKGER.

scientific article published on April 2014

Collagen XXIII, novel ligand for integrin alpha2beta1 in the epidermis

scientific article

Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain

scientific journal article

Epithelial Anion Transport as Modulator of Chemokine Signaling

scientific article

Expression of type XXIII collagen mRNA and protein

scientific article

Extracellular oxidation in Cystic Fibrosis airway epithelium causes enhanced EGFR/ADAM17 activity

scientific article published on 14 December 2017

From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations

scientific article published on February 2016

Mutation-specific downregulation of CFTR2 variants by gating potentiators

scientific article published on 4 October 2017

Potentiators of Defective ΔF508-CFTR Gating that Do Not Interfere with Corrector Action.

scientific article

Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice.

scientific article published on 11 December 2013

Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect

scientific article

Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.

scientific article published on July 2014

Structure-guided combination therapy to potently improve the function of mutant CFTRs

article

Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.

scientific article

Transcytosis maintains CFTR apical polarity in the face of constitutive and mutation-induced basolateral missorting

scientific article published on 15 May 2019

Type XIV Collagen Regulates Fibrillogenesis: PREMATURE COLLAGEN FIBRIL GROWTH AND TISSUE DYSFUNCTION IN NULL MICE.

scientific article

ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter

scientific article published on 13 March 2018

List of works by Guido Veit

Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity

Chaperone-Independent Peripheral Quality Control of CFTR by RFFL E3 Ligase.

Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.

Collagen XII interacts with avian tenascin-X through its NC3 domain

Collagen XXII binds to collagen-binding integrins via the novel motifs GLQGER and GFKGER.

Collagen XXIII, novel ligand for integrin alpha2beta1 in the epidermis

Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain

Epithelial Anion Transport as Modulator of Chemokine Signaling

Expression of type XXIII collagen mRNA and protein

Extracellular oxidation in Cystic Fibrosis airway epithelium causes enhanced EGFR/ADAM17 activity

From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations

Mutation-specific downregulation of CFTR2 variants by gating potentiators

Potentiators of Defective ΔF508-CFTR Gating that Do Not Interfere with Corrector Action.

Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice.

Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect

Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.

Structure-guided combination therapy to potently improve the function of mutant CFTRs

Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.

Transcytosis maintains CFTR apical polarity in the face of constitutive and mutation-induced basolateral missorting

Type XIV Collagen Regulates Fibrillogenesis: PREMATURE COLLAGEN FIBRIL GROWTH AND TISSUE DYSFUNCTION IN NULL MICE.

ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter